Pfizer logo 25.11.21

CHMP has recommended that the indication for COVID-19 vaccine from Pfizer-BioNTech be expanded to children 5 to 11 years of age. The immunization is proposed to be administered in two doses of 10 mcg, three weeks apart. CHMP will now send its recommendation to the European Commission, which will make the final decision.